Angio Care China Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
5
Angio Care China General Information
Description
Researcher and provider of medical consumables and equipment. The company focuses on the development, production and sales of high-end innovative medical consumables and equipment for the treatment of hypertension, aiming to provide customers with the latest and most reliable products on the market.
Contact Information
Website
www.angiocare.com.cn(Operating Subsidiary)
Corporate Office
- Room 301, Building B, Building 6, No. 590
- Ruiqing Road, Pudong New Area
- Shanghai, 201201
- China
Corporate Office
- Room 301, Building B, Building 6, No. 590
- Ruiqing Road, Pudong New Area
- Shanghai, 201201
- China
Angio Care China Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Angio Care China Patents
Angio Care China Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2017132935-A1 | Multi-electrode renal artery ablation catheter | Inactive | 04-Feb-2016 | ||
| WO-2014176785-A1 | Nerve regulation device | Inactive | 03-May-2013 | ||
| EP-2990070-A1 | Ablation catheter | Inactive | 26-Apr-2013 | ||
| JP-5955457-B2 | Ablation catheter | Inactive | 26-Apr-2013 | ||
| JP-WO2014174662-A1 | Ablation catheter | Active | 26-Apr-2013 | A61B18/1492 |
Angio Care China FAQs
-
When was Angio Care China founded?
Angio Care China was founded in 2011.
-
Where is Angio Care China headquartered?
Angio Care China is headquartered in Shanghai, China.
-
What industry is Angio Care China in?
Angio Care China’s primary industry is Other Devices and Supplies.
-
Is Angio Care China a private or public company?
Angio Care China is a Private company.
-
What is Angio Care China’s current revenue?
The current revenue for Angio Care China is .
-
When was Angio Care China acquired?
Angio Care China was acquired on 03-Mar-2022.
-
Who acquired Angio Care China?
Angio Care China was acquired by Shanghai Bioxin Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process